Springuel, Lorraine
Lonez, Caroline http://orcid.org/0000-0002-9230-3855
Alexandre, Bertrand
Van Cutsem, Eric
Machiels, Jean-Pascal H.
Van Den Eynde, Marc
Prenen, Hans
Hendlisz, Alain
Shaza, Leila
Carrasco, Javier
Canon, Jean-Luc
Opyrchal, Mateusz
Odunsi, Kunle
Rottey, Sylvie
Gilham, David E.
Flament, Anne
Lehmann, Frédéric F.
Article History
First Online: 30 July 2019
Compliance with Ethical Standards
:
: No external funding was used in the preparation of this review.
: Lorraine Springuel, Caroline Lonez, Bertrand Alexandre, David E. Gilham, Anne Flament, and Frédéric F. Lehmann are employees of Celyad SA. Mateusz Opyrchal has consulting agreements with Novartis and AstraZeneca, and has received research funding from Pfizer and Bayer. Eric Van Cutsem reports participation in advisory boards for AstraZeneca, Bayer, Bristol-Myers Squibb, Celgene, Lilly, Merck Sharp & Dohme, Merck KGaA, Novartis, Roche, and Servier and research grants from Amgen, Bayer, Boehringer Ingelheim, Celgene, Ipsen, Lilly, Roche, Merck Sharp & Dohme, Merck KGaA, Novartis, Roche, and Servier paid to his institution (Cliniques Universitaires Saint-Luc) outside the submitted work. Jean-Pascal H. Machiels, Marc Van Den Eynde, Hans Prenen, Alain Hendlisz, Eric Van Cutsem, Leila Shaza, Javier Carrasco, Jean-Luc Canon, Mateusz Opyrchal, Kunle Odunsi, and Sylvie Rottey are investigators on Celyad’s sponsored trials.